Welcome to LookChem.com Sign In|Join Free
  • or
4-(QUINAZOLIN-4-YLAMINO)-BENZOIC ACID is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

33683-30-6

Post Buying Request

33683-30-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

33683-30-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 33683-30-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,6,8 and 3 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 33683-30:
(7*3)+(6*3)+(5*6)+(4*8)+(3*3)+(2*3)+(1*0)=116
116 % 10 = 6
So 33683-30-6 is a valid CAS Registry Number.

33683-30-6Relevant academic research and scientific papers

Effect of Derivatives of Hydroxamic Acids on Vasculogenic Mimicry

Balaev, A. N.,Khachatryan, D. S.,Khochenkov, D. A.,Khochenkova, Yu. A.,Kolotaev, A. V.,Machkova, Yu. S.,Ohmanovich, K. A.,Osipov, V. N.,Vartanian, A. A.

, p. 252 - 263 (2020)

Abstract—: Vasculogenic mimicry, the formation of vascular channels lined with tumor cells of a highly malignant phenotype, is currently considered as an additional system of blood supply of the tumor. Experimental studies in vivo have repeatedly demonstrated that vascular channels form in the areas of a tumor with a low density of blood vessels. It is supposed that the formation of a network of these channels inside the tumor maintains homeostasis and prevents early necrosis within it. In this work, bifunctional compounds based on a combination of quinazoline and hydroxamic acid in one molecule were examined for the ability to inhibit the migration of tumor cells and vasculogenic mimicry.

PIPERAZINYLPYRIMIDINE ANALOGUES AS PROTEIN KINASE INHIBITORS

-

Page/Page column 17, (2012/03/12)

The invention provides novel compounds based on piperazinylpyrimidine derivatives to be used as protein kinase inhibitors. The compounds may be useful in treating or preventing different cellular proliferation disorders, such as cancer. The present invent

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 33683-30-6